Focus Partners Wealth Lowers Stock Position in Transcat, Inc. (NASDAQ:TRNS)

Focus Partners Wealth cut its holdings in Transcat, Inc. (NASDAQ:TRNS) by 3.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,762 shares of the scientific and technical instruments company’s stock after selling 388 shares during the quarter. Focus Partners Wealth’s holdings in Transcat were worth $1,349,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Barclays PLC grew its holdings in Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock worth $1,826,000 after purchasing an additional 12,061 shares during the period. Annex Advisory Services LLC boosted its position in shares of Transcat by 47.6% in the 4th quarter. Annex Advisory Services LLC now owns 24,461 shares of the scientific and technical instruments company’s stock worth $2,587,000 after purchasing an additional 7,893 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Transcat in the 4th quarter worth approximately $182,000. Linden Thomas Advisory Services LLC increased its position in Transcat by 23.2% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 6,477 shares of the scientific and technical instruments company’s stock valued at $685,000 after buying an additional 1,219 shares in the last quarter. Finally, Catawba River Capital raised its stake in Transcat by 2.2% during the fourth quarter. Catawba River Capital now owns 67,300 shares of the scientific and technical instruments company’s stock valued at $7,116,000 after buying an additional 1,473 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on TRNS. StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. HC Wainwright decreased their target price on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Finally, Northland Securities reiterated a “market perform” rating and issued a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $111.50.

Transcat Trading Up 0.4%

Transcat stock opened at $81.25 on Friday. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12. The business’s fifty day moving average is $77.67 and its 200 day moving average is $89.95. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The stock has a market capitalization of $756.36 million, a PE ratio of 43.92 and a beta of 0.69.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.